Powered by

Luminex Corporation Completes Acquisition of MilliporeSigma's Flow Cytometry Portfolio

Jan 02, 2019 - PR Newswire
Mergers and Acquisitions

PR Newswire

 Luminex Corporation (NASDAQ: LMNX) today announced that the company has completed its previously announced acquisition of MilliporeSigma's flow cytometry portfolio for $75 million in combined stock, asset and inventory purchases. The acquisition is expected to contribute $40 million to $50 million in revenue to Luminex in 2019.

"We are pleased to announce the completion of this transaction and excited to welcome the talented MilliporeSigma flow cytometry team to the Lu...